Staff Profile

I am a Clinical Research Associate with the Biosciences Institute under the supervision of Dr Laura Jardine and a haematology specialty trainee with an honorary contract at Newcastle upon Tyne Hospitals. My clinical area of interest is lymphoma, and my PhD will focus on precision targeting in primary CNS lymphoma through single-cell multi-omics.

I am based within the Haniffa Lab in the Biosciences Institute. 

• Nicolson P, Perry R, Buka R, Fisher A, Pickard K, Toh CH, Lowe G, Hill Q, et al. A single 1 g/kg dose of intravenous immunoglobulin is a safe and effective treatment for immune thrombocytopenia; results of the first HaemSTAR ‘Flash-Mob’ retrospective study incorporating 961 patients. British Journal of Haematology 2022, 196(2), 433-437.
• Jardine L, Webb S, Goh I, Londono M, Reynolds G, Mather MP, Pickard K, Teichmann S, Haniffa M, et al. Blood and immune development in human fetal bone marrow and Down syndrome. Nature 2021, 598, 327-331.
• Di Ciaccio P, Polizzotto M, Cwynarski K, Burton C, Awachana J, Bower M, Pickard K, Hamad N, et al. Survival outcomes for plasmablastic lymphoma: an international, multicentre study by the Australasian Lymphoma Alliance. In: 62nd ASH Annual Meeting. 2020, American Society of Hematology.
• Pickard K, Williams C, Watson H, McGregor A. Leukaemic relapse of angioimmunoblastic T-cell lymphoma. Br J Haematol 2020, 189, 592.
• McCulloch R, Bull T, Nicolson P, Shaw R, Pickard K, Scully M, et al. Factors influencing time from initial presentation to start of plasma exchange (PEX) in patients with acute thrombotic thrombocytopenic purpura (TTP). In: 62nd ASH Annual Meeting. 2020, Virtual: American Society of Hematology.
• Pickard K, Fisher J. Blood, no sweat and no tears: a novel approach to teaching transfusion‐associated circulatory overload. Transfusion Med 2019, 29, 284-286.
• Pickard K, Harris S. High flow nasal oxygen therapy. British Journal of Hospital Medicine 2018, 79(1), 2-4.
• Pickard K. Long term oxygen therapy. InnovAiT 2015, 8(8), 455-461.